Skip to main content
. 2021 May 7;11:9751. doi: 10.1038/s41598-021-89164-w

Table 1.

Descriptive statistics of patient characteristics for all pediatric aortic valve (AV) tissue samples featured in the study.

SKU Age (years) Pediatric age group Gender Race/ethnicity BSA (m2) Leaflet morphology Aortic valve function
Normal
DB017 0.5 Infant M 0.38 Trileaflet Normal
DB051 0.66 Infant M C 0.34 Trileaflet Normal
NDRI 2 Young child M L 0.63 Trileaflet Not recorded
DB85 9 Child F C 0.95 Trileaflet Normal
DB27 17 Adolescent M C 2.2 Trileaflet Normal
Normal Averages 7.17 ± 7.5 75%M 25%F 75%C 25%L 1.03
pCAVS
DB106 0.04 Neonate M C 0.21 Bicuspid Severe stenosis with AVI
DB43 0.15 Infant M C 0.24 Trileaflet Moderate stenosis with AVI*
DB40 0.75 Infant M C 0.37 Bicuspid Moderate stenosis
DB105 5 Young child M C 0.72 Bicuspid Moderate stenosis with AVI
DB119 5 Young child F Bicuspid Moderate stenosis with AVI
DB113 5 Young child Trivial stenosis; severe AVI
DB18 6 Child F C 0.7 Bicuspid Moderate stenosis with AVI
DB3 11 Child F C 1.5 Bicuspid Moderate stenosis with AVI
DB117 12 Adolescent M Bicuspid Moderate stenosis with AVI
DB41 14 Adolescent M C 1.6 Bicuspid Moderate stenosis with AVI
DB16 17 Adolescent M C 2.1 Bicuspid Moderate stenosis with AVI
pCAVS Averages 6.90 ± 5.8 70%M 30%F 100%C 0.93
AVI
DB114 0.17 Infant F Trileaflet Trivial AVI
DB007 0.58 Infant Trileaflet Mild nAVI
DB108 10 Child F C 1.3 Trileaflet Thickened with AVI
DB83 10 Child F AA 1.4 Trileaflet Trivial AVI
DB032 16 Adolescent Trileaflet Mild nAVI
AVI Averages 7.35 ± 6.8 1.35

Normal AVs are from cardiac transplant patients where normal AV function is define by 2D echocardiogram. 2D Echocardiogram mean gradients define pre-operative AV function where a normal gradient is defined as < 5 mmHg, mild stenosis as 5–25 mmHg, moderate stenosis as 25–50 mmHg, and severe stenosis as > 50 mmHg. BSA: body surface area; C: Caucasian; L: Latino; AA: African American; MD: Myxomatous Degeneration. DB43 was included in pCAVS due to stenosis, but main diagnosis was Hypertrophic Cardiomyopathy. Pediatric Age Groups are defined by National Institute of Child and Human Development: Neonate (0–30d), Infant (1 mo–2yrs), young Child (2–6 yrs), Child (6–12 yrs), Adolescent (12–18 yrs). Experiment information can be seen in Supplemental Table S5.